Tg Therapeutics (TGTX) Interest & Investment Income (2012 - 2019)
Tg Therapeutics (TGTX) posted quarterly Interest & Investment Income of $1.1 million for Q2 2019, up 382.96% year-over-year from $223000.0 in Q2 2018, and up 622.82% quarter-over-quarter from $149000.0 in Q1 2019.
Powered by 
Analysis
Tg Therapeutics (TGTX) Interest & Investment Income (2012 - 2019) Analysis & Trends
Tg Therapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.1 million for Q2 2019.
- In Q2 2019, Interest & Investment Income rose 382.96% year-over-year to $1.1 million; the TTM figure through Jun 2019 stood at $1.8 million (up 208.64% YoY), while the FY2018 annual figure was $857000.0, up 190.51% from the prior year.
- Interest & Investment Income for Q2 2019 stood at $1.1 million, up from $149000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.1 million in Q2 2019, with the low at $22132.0 in Q1 2015.
- The 5-year median for Interest & Investment Income is $86413.5 (2016), against an average of $161647.4.
- The sharpest annual moves came in 2017 and 2019: Interest & Investment Income slumped 46.97% in 2017, then surged 382.96% in 2019.
- Tg Therapeutics' Interest & Investment Income stood at $64993.0 in 2015, then retreated by 11.46% to $57544.0 in 2016, then surged by 110.27% to $121000.0 in 2017, then surged by 119.83% to $266000.0 in 2018, then jumped by 304.89% to $1.1 million in 2019.
- Business Quant data shows TGTX's Interest & Investment Income at $1.1 million in Q2 2019, $149000.0 in Q1 2019, and $266000.0 in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Tg Therapeutics | 7.93 Bn | 7.25 Bn | 199.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 149,000.00 |
| Dec 31, 2018 | 266,000.00 |
| Sep 30, 2018 | 258,000.00 |
| Jun 30, 2018 | 223,000.00 |
| Mar 31, 2018 | 144,000.00 |
| Dec 31, 2017 | 121,000.00 |
| Sep 30, 2017 | 79,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 45,000.00 |
| Dec 31, 2016 | 57,544.00 |
| Sep 30, 2016 | 87,965.00 |
| Jun 30, 2016 | 92,629.00 |
| Mar 31, 2016 | 84,862.00 |
| Dec 31, 2015 | 64,993.00 |
| Sep 30, 2015 | 55,977.00 |
| Jun 30, 2015 | 31,551.00 |
| Mar 31, 2015 | 22,132.00 |
| Dec 31, 2014 | 16,741.00 |
| Sep 30, 2014 | 12,107.00 |